Record Display for the EPA National Library Catalog

RECORD NUMBER: 48 OF 58

OLS Field Name OLS Field Data
Main Title Regulatory impact assessment of proposed effluent guidelines for the pharmaceutical manufacturing industry [Microfiche] : final report.
CORP Author Environmental Protection Agency, Washington, DC. Office of Water.
Publisher U.S. Environmental Protection Agency, Engineering and Analysis Division, Office of Science and Technology, Office of Water,
Year Published 1995
Report Number EPA/821/R-95/017
Stock Number PB95-219812
Subjects Drug factories--Waste disposal--Standards--United States. ; Drug factories--Environmental aspects--Standards--United States. ; Effluent quality--Standards--United States. ; Water--Pollution--United States--Point source identification.
Additional Subjects Drug industry ; Water pollution control ; Economic impact ; Chemical effluents ; Industrial plants ; Pollution regulations ; Cost benefit analysis ; Pharmaceutical industry
Internet Access
Description Access URL
http://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=200033F1.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB95-219812 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 01/01/1988
Collation 1 volume (various pagings) ; 28 cm
Abstract
The report has been prepared to comply with Executive Order 12866, which requires federal agencies to assess the costs and benefits of each significant rule they propose or promulgate. The regulations for the pharmaceutical industry, which are proposed by the U.S. Environmental Protection Agency (EPA, or the Agency), meet the Order's definition of a significant rule. The Agency has assessed both costs and benefits of the proposed rule, as presented in this Regulatory Impact Assessment (RIA).
Notes
"February 1995." Includes bibliographical references. "EPA 821-R-95-017"--Cover. Microfiche.